Changes in regional brain metabolism following aromatase inhibitor therapy in postmenopausal women

被引：0

作者：

Silverman, Daniel ^{[1
]}

Lee, Soo ^{[1
]}

Geist, Cheri ^{[1
]}

Yang, Chine Ching ^{[1
]}

Togawa, Kayo ^{[2
]}

Katheria, Vani ^{[2
]}

Hansen, Kurt ^{[2
]}

Patel, Sunita ^{[2
]}

Czernin, Johannes ^{[1
]}

Hurria, Arti ^{[2
]}

机构：

[1] Univ Calif Los Angeles, Los Angeles, CA USA

[2] City Hope Natl Med Ctr, Duarte, CA USA

来源：

JOURNAL OF NUCLEAR MEDICINE | 2010年 / 51卷

关键词：

D O I：

暂无

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

1803

引用

页数：1

共 50 条

[21] Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer
Gnant, Michael
Fitzal, Florian
Rinnerthaler, Gabriel
Steger, Guenther G.
Greil-Ressler, Sigrun
Balic, Marija
Heck, Dietmar
Jakesz, Raimund
Thaler, Josef
Egle, Daniel
Manfreda, Diether
Bjelic-Radisic, Vesna
Wieder, Ursula
Singer, Christian F.
Melbinger-Zeinitzer, Elisabeth
Haslbauer, Ferdinand
Sevelda, Paul
Trapl, Harald
Wette, Viktor
Wimmer, Kerstin
Gampenrieder, Simon P.
Bartsch, Rupert
Kacerovsky-Strobl, Stephanie
Suppan, Christoph
Brunner, Christine
Deutschmann, Christine
Soelkner, Lidija
Fesl, Christian
Greil, Richard
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (05): : 395 - 405
[22] AROMATASE INHIBITOR- INDUCED CHANGES IN THE LIPID PROFILE OF POSTMENOPAUSAL WOMEN WITH EARLY STAGE BREAST CANCER.
Bell, L. N.
Nguyen, A. T.
Li, L.
Desta, Z.
Flockhart, D. A.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S79 - S79
[23] Time Course of Arthralgia Among Women Initiating Aromatase Inhibitor Therapy Compared with Postmenopausal Women Without Cancer in a Prospective Cohort
Castel, Liana D.
Hartmann, Katherine E.
Mayer, Ingrid A.
Boomershine, Chad S.
Abramson, Vandana G.
Chakravarthy, Anuradha Bapsi
Johnson, David H.
Cella, David F.
JOURNAL OF WOMENS HEALTH, 2012, 21 (10) : 990 - 990
[24] Time course of arthralgia among women initiating aromatase inhibitor therapy and a postmenopausal comparison group in a prospective cohort
Castel, Liana D.
Hartmann, Katherine E.
Mayer, Ingrid A.
Saville, Benjamin R.
Alvarez, JoAnn
Boomershine, Chad S.
Abramson, Vandana G.
Chakravarthy, A. Bapsi
Friedman, Debra L.
Cella, David F.
CANCER, 2013, 119 (13) : 2375 - 2382
[25] Investigation of Combination Treatment With an Aromatase Inhibitor Exemestane and Carboplatin- Based Therapy for Postmenopausal Women With Advanced NSCLC
Young, Patricia A.
Marquez-Garban, Diana C.
Noor, Zorawar Singh
Moatamed, Neda
Elashoff, David
Grogan, Tristan
Romero, Tahmineh
Sasano, Hironobu
Saito, Ryoko
Rausch, Rebecca
Hamilton, Nalo
Dubinett, Steven M.
Garon, Edward B.
Pietras, Richard J.
JTO CLINICAL AND RESEARCH REPORTS, 2021, 2 (04):
[26] Obesity and NonAdherence Correlate with Elevated Serum Estradiol Levels in Postmenopausal Women Receiving Adjuvant Aromatase Inhibitor Therapy
Decker, David A.
Reynolds, Robert B.
Molthrop, David C.
Griffith, Elizabeth
Encarnacion, Tiffany
Lee, Eimon
Zhu, Xiang
BREAST JOURNAL, 2014, 20 (05): : 553 - 554
[27] Adjuvant Aromatase Inhibitor Options in Overweight and Obese Postmenopausal Women with Breast Cancer
Chlebowski, Rowan T.
BREAST JOURNAL, 2013, 19 (05): : 552 - 554
[28] Treatment of benign uterine bleeding in morbidly obese postmenopausal women with an aromatase inhibitor
Stovall, D.
HUMAN REPRODUCTION, 2023, 38
[29] Association of adjuvant aromatase inhibitor with cataract risk in postmenopausal women with breast cancer
Chen, Han
Shao, Zhi-Ming
Yu, Ke-Da
Xu, Ge-Zhi
ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (06)
[30] Summary of aromatase inhibitor clinical trials in postmenopausal women with early breast cancer
Buzdar, Aman U.
Coombes, R. Charles
Goss, Paul E.
Winer, Eric P.
CANCER, 2008, 112 (03) : 700 - 709

← 1 2 3 4 5 →